* Senior Scientist Opportunity - Texas *QP Group is currently partnered with a clinical-stage, Series A-backed biotech developing a neonatal progenitor cell therapy for rare cardiomyopathies, with its lead programme advancing towards pivotal trials in a neuromuscular disease-related heart condition. a Scientist/Senior Scientist to support the Analytical Development within the CMC Group. This role will be responsible for characterization of cell products and processes and will work closely with the Process Development team and external partners such as CDMOs and collaborators.
Responsibilities:
Development and optimization of analytical methods and potency assays for the characterization of cell therapy products, including those based on Flow Cytometry, ELISA, and qPCR
Collaboration with CDMOs and CTLs to facilitate Tech Transfer of analytical methods
Support additional projects and business needs as assigned
Execution of analytical testing for in-process samples, cell banks and cell products
Experience Required:
PhD or Master's degree in cell biology, immunology, biochemistry, or bioengineering
5+ years of experience in analytical development, analytical/product characterization for cell therapy or gene therapy drug products
Experience with Flow Cytometry assays and their development to qualification
Strong background in experimental design and result interpretation
Ability to optimize and performance-evaluate characterization methods to ensure they are scientifically sound and fit for purpose, documenting outcomes in protocols and reports
Strong written and verbal communication skills
Ability to work independently, manage priorities, and collaborate effectively in a small-company environment
